Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder

.

Bibliographic Details
Main Authors: P. F. Mulders, K. Miller, N. S. Tchekmedyian
Format: Article
Language:Russian
Published: ABV-press 2020-02-01
Series:Onkourologiâ
Online Access:https://oncourology.abvpress.ru/oncur/article/view/1046
Description
Summary:.
ISSN:1726-9776
1996-1812